aluates Reports

$ 0.0

Automative

Chickenpox (Varicella) Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-11V8704

Global Chickenpox Varicella Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Chickenpox (Varicella) Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11V8704

Report

September 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Sanofi Pasteur

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Chickenpox (Varicella) Vaccine - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chickenpox (Varicella) Vaccine - Market

The global market for Chickenpox (Varicella) Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chickenpox (Varicella) Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chickenpox (Varicella) Vaccine by region & country, by Type, and by Application.

The Chickenpox (Varicella) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chickenpox (Varicella) Vaccine.

Market Segmentation

Scope of Chickenpox (Varicella) Vaccine - Market Report

Report Metric	Details
Report Name	Chickenpox (Varicella) Vaccine - Market
CAGR	5%
Segment by Type:	Monovalent Vaccine Combination Vaccine
Segment by Application	Kids Injection Adults Injection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & Co., Sanofi Pasteur, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Chickenpox (Varicella) Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Chickenpox (Varicella) Vaccine - Market report?

Ans: The main players in the Chickenpox (Varicella) Vaccine - Market are Merck & Co., Sanofi Pasteur, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the Chickenpox (Varicella) Vaccine - Market report?

Ans: The Applications covered in the Chickenpox (Varicella) Vaccine - Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Chickenpox (Varicella) Vaccine - Market report?

Ans: The Types covered in the Chickenpox (Varicella) Vaccine - Market report are Monovalent Vaccine, Combination Vaccine

Recommended Reports

Vaccine Market Overview

Pediatric & Preventive Vaccines

Vaccine Technologies & Accessories

1 Market Overview

1.1 Chickenpox (Varicella) Vaccine Product Introduction

1.2 Global Chickenpox (Varicella) Vaccine Market Size Forecast

1.2.1 Global Chickenpox (Varicella) Vaccine Sales Value (2019-2030)

1.2.2 Global Chickenpox (Varicella) Vaccine Sales Volume (2019-2030)

1.2.3 Global Chickenpox (Varicella) Vaccine Sales Price (2019-2030)

1.3 Chickenpox (Varicella) Vaccine Market Trends & Drivers

1.3.1 Chickenpox (Varicella) Vaccine Industry Trends

1.3.2 Chickenpox (Varicella) Vaccine Market Drivers & Opportunity

1.3.3 Chickenpox (Varicella) Vaccine Market Challenges

1.3.4 Chickenpox (Varicella) Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Chickenpox (Varicella) Vaccine Players Revenue Ranking (2023)

2.2 Global Chickenpox (Varicella) Vaccine Revenue by Company (2019-2024)

2.3 Global Chickenpox (Varicella) Vaccine Players Sales Volume Ranking (2023)

2.4 Global Chickenpox (Varicella) Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Chickenpox (Varicella) Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Chickenpox (Varicella) Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Chickenpox (Varicella) Vaccine

2.9 Chickenpox (Varicella) Vaccine Market Competitive Analysis

2.9.1 Chickenpox (Varicella) Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Chickenpox (Varicella) Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Monovalent Vaccine

3.1.2 Combination Vaccine

3.2 Global Chickenpox (Varicella) Vaccine Sales Value by Type

3.2.1 Global Chickenpox (Varicella) Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Chickenpox (Varicella) Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Chickenpox (Varicella) Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Chickenpox (Varicella) Vaccine Sales Volume by Type

3.3.1 Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Chickenpox (Varicella) Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Chickenpox (Varicella) Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Chickenpox (Varicella) Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Kids Injection

4.1.2 Adults Injection

4.2 Global Chickenpox (Varicella) Vaccine Sales Value by Application

4.2.1 Global Chickenpox (Varicella) Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Chickenpox (Varicella) Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Chickenpox (Varicella) Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Chickenpox (Varicella) Vaccine Sales Volume by Application

4.3.1 Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Chickenpox (Varicella) Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Chickenpox (Varicella) Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Chickenpox (Varicella) Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Chickenpox (Varicella) Vaccine Sales Value by Region

5.1.1 Global Chickenpox (Varicella) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Chickenpox (Varicella) Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Chickenpox (Varicella) Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Chickenpox (Varicella) Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Chickenpox (Varicella) Vaccine Sales Volume by Region

5.2.1 Global Chickenpox (Varicella) Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Chickenpox (Varicella) Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Chickenpox (Varicella) Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Chickenpox (Varicella) Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Chickenpox (Varicella) Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

5.4.2 North America Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

5.5.2 Europe Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

5.7.2 South America Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value

6.2.1 Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.3.2 United States Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.4.2 Europe Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.5.2 China Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.6.2 Japan Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.7.2 South Korea Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Chickenpox (Varicella) Vaccine Sales Value, 2019-2030

6.9.2 India Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Chickenpox (Varicella) Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck & Co.

7.1.1 Merck & Co. Company Information

7.1.2 Merck & Co. Introduction and Business Overview

7.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Offerings

7.1.5 Merck & Co. Recent Development

7.2 Sanofi Pasteur

7.2.1 Sanofi Pasteur Company Information

7.2.2 Sanofi Pasteur Introduction and Business Overview

7.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Offerings

7.2.5 Sanofi Pasteur Recent Development

7.3 GSK

7.3.1 GSK Company Information

7.3.2 GSK Introduction and Business Overview

7.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GSK Chickenpox (Varicella) Vaccine Product Offerings

7.3.5 GSK Recent Development

7.4 Shanghai Institute

7.4.1 Shanghai Institute Company Information

7.4.2 Shanghai Institute Introduction and Business Overview

7.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Offerings

7.4.5 Shanghai Institute Recent Development

7.5 BCHT

7.5.1 BCHT Company Information

7.5.2 BCHT Introduction and Business Overview

7.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 BCHT Chickenpox (Varicella) Vaccine Product Offerings

7.5.5 BCHT Recent Development

7.6 Changsheng

7.6.1 Changsheng Company Information

7.6.2 Changsheng Introduction and Business Overview

7.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Changsheng Chickenpox (Varicella) Vaccine Product Offerings

7.6.5 Changsheng Recent Development

7.7 Keygen

7.7.1 Keygen Company Information

7.7.2 Keygen Introduction and Business Overview

7.7.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Keygen Chickenpox (Varicella) Vaccine Product Offerings

7.7.5 Keygen Recent Development

7.8 Green Cross

7.8.1 Green Cross Company Information

7.8.2 Green Cross Introduction and Business Overview

7.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Green Cross Chickenpox (Varicella) Vaccine Product Offerings

7.8.5 Green Cross Recent Development

7.9 Biken

7.9.1 Biken Company Information

7.9.2 Biken Introduction and Business Overview

7.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Biken Chickenpox (Varicella) Vaccine Product Offerings

7.9.5 Biken Recent Development

8 Industry Chain Analysis

8.1 Chickenpox (Varicella) Vaccine Industrial Chain

8.2 Chickenpox (Varicella) Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Chickenpox (Varicella) Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Chickenpox (Varicella) Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Merck

Sanofi Pasteur

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

List of Tables

Table 1. Chickenpox (Varicella) Vaccine Market Trends

Table 2. Chickenpox (Varicella) Vaccine Market Drivers & Opportunity

Table 3. Chickenpox (Varicella) Vaccine Market Challenges

Table 4. Chickenpox (Varicella) Vaccine Market Restraints

Table 5. Global Chickenpox (Varicella) Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Chickenpox (Varicella) Vaccine Sales Volume by Company (2019-2024) & (K Doses)

Table 8. Global Chickenpox (Varicella) Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Chickenpox (Varicella) Vaccine Price by Company (2019-2024) & (USD/dose)

Table 10. Key Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Chickenpox (Varicella) Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Chickenpox (Varicella) Vaccine

Table 13. Global Chickenpox (Varicella) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Chickenpox (Varicella) Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Chickenpox (Varicella) Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Chickenpox (Varicella) Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Chickenpox (Varicella) Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)

Table 22. Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2019-2024) & (K Doses)

Table 23. Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2025-2030) & (K Doses)

Table 24. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Chickenpox (Varicella) Vaccine Price by Type (2019-2024) & (USD/dose)

Table 27. Global Chickenpox (Varicella) Vaccine Price by Type (2025-2030) & (USD/dose)

Table 28. Global Chickenpox (Varicella) Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Chickenpox (Varicella) Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Chickenpox (Varicella) Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Chickenpox (Varicella) Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)

Table 34. Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2019-2024) & (K Doses)

Table 35. Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2025-2030) & (K Doses)

Table 36. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Chickenpox (Varicella) Vaccine Price by Application (2019-2024) & (USD/dose)

Table 39. Global Chickenpox (Varicella) Vaccine Price by Application (2025-2030) & (USD/dose)

Table 40. Global Chickenpox (Varicella) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Chickenpox (Varicella) Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Chickenpox (Varicella) Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Chickenpox (Varicella) Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Chickenpox (Varicella) Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Chickenpox (Varicella) Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030

Table 46. Global Chickenpox (Varicella) Vaccine Sales Volume by Region (2019-2024) & (K Doses)

Table 47. Global Chickenpox (Varicella) Vaccine Sales Volume by Region (2025-2030) & (K Doses)

Table 48. Global Chickenpox (Varicella) Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Chickenpox (Varicella) Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Chickenpox (Varicella) Vaccine Average Price by Region (2019-2024) & (USD/dose)

Table 51. Global Chickenpox (Varicella) Vaccine Average Price by Region (2025-2030) & (USD/dose)

Table 52. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Volume, (2019-2024) & (K Doses)

Table 56. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Volume, (2025-2030) & (K Doses)

Table 57. Merck & Co. Company Information

Table 58. Merck & Co. Introduction and Business Overview

Table 59. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 60. Merck & Co. Chickenpox (Varicella) Vaccine Product Offerings

Table 61. Merck & Co. Recent Development

Table 62. Sanofi Pasteur Company Information

Table 63. Sanofi Pasteur Introduction and Business Overview

Table 64. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 65. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Offerings

Table 66. Sanofi Pasteur Recent Development

Table 67. GSK Company Information

Table 68. GSK Introduction and Business Overview

Table 69. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 70. GSK Chickenpox (Varicella) Vaccine Product Offerings

Table 71. GSK Recent Development

Table 72. Shanghai Institute Company Information

Table 73. Shanghai Institute Introduction and Business Overview

Table 74. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 75. Shanghai Institute Chickenpox (Varicella) Vaccine Product Offerings

Table 76. Shanghai Institute Recent Development

Table 77. BCHT Company Information

Table 78. BCHT Introduction and Business Overview

Table 79. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 80. BCHT Chickenpox (Varicella) Vaccine Product Offerings

Table 81. BCHT Recent Development

Table 82. Changsheng Company Information

Table 83. Changsheng Introduction and Business Overview

Table 84. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 85. Changsheng Chickenpox (Varicella) Vaccine Product Offerings

Table 86. Changsheng Recent Development

Table 87. Keygen Company Information

Table 88. Keygen Introduction and Business Overview

Table 89. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 90. Keygen Chickenpox (Varicella) Vaccine Product Offerings

Table 91. Keygen Recent Development

Table 92. Green Cross Company Information

Table 93. Green Cross Introduction and Business Overview

Table 94. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 95. Green Cross Chickenpox (Varicella) Vaccine Product Offerings

Table 96. Green Cross Recent Development

Table 97. Biken Company Information

Table 98. Biken Introduction and Business Overview

Table 99. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)

Table 100. Biken Chickenpox (Varicella) Vaccine Product Offerings

Table 101. Biken Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Chickenpox (Varicella) Vaccine Downstream Customers

Table 105. Chickenpox (Varicella) Vaccine Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Chickenpox (Varicella) Vaccine Product Picture

Figure 2. Global Chickenpox (Varicella) Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Chickenpox (Varicella) Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Chickenpox (Varicella) Vaccine Sales Volume (2019-2030) & (K Doses)

Figure 5. Global Chickenpox (Varicella) Vaccine Sales Price (2019-2030) & (USD/dose)

Figure 6. Chickenpox (Varicella) Vaccine Report Years Considered

Figure 7. Global Chickenpox (Varicella) Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Chickenpox (Varicella) Vaccine Players Sales Volume Ranking (2023) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox (Varicella) Vaccine Revenue in 2023

Figure 10. Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Monovalent Vaccine Picture

Figure 12. Combination Vaccine Picture

Figure 13. Global Chickenpox (Varicella) Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Chickenpox (Varicella) Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)

Figure 16. Global Chickenpox (Varicella) Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Chickenpox (Varicella) Vaccine Price by Type (2019-2030) & (USD/dose)

Figure 18. Product Picture of Kids Injection

Figure 19. Product Picture of Adults Injection

Figure 20. Global Chickenpox (Varicella) Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Chickenpox (Varicella) Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)

Figure 23. Global Chickenpox (Varicella) Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Chickenpox (Varicella) Vaccine Price by Application (2019-2030) & (USD/dose)

Figure 25. North America Chickenpox (Varicella) Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Chickenpox (Varicella) Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Chickenpox (Varicella) Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Chickenpox (Varicella) Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Chickenpox (Varicella) Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Chickenpox (Varicella) Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Chickenpox (Varicella) Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Chickenpox (Varicella) Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Chickenpox (Varicella) Vaccine Industrial Chain

Figure 59. Chickenpox (Varicella) Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vaccines Market Research Report 2025

Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poxviridae Infections Drug Market Research Report 2025

Zoster Vaccine Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genital Herpes Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bordetella Vaccine for Dogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions